HaiHa Confectionery Joint - Stock Company (HNX:HHC)
Vietnam · Delayed Price · Currency is VND 100,000
0.00 (0.00%)
At close: Aug 4, 2025
Theseus Pharmaceuticals Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 772,251 | 866,319 | 1,454,563 | 930,609 | 1,408,828 | Upgrade | |
Revenue Growth (YoY) | -10.86% | -40.44% | 56.30% | -33.94% | 34.35% | Upgrade |
Cost of Revenue | 602,660 | 690,885 | 1,258,883 | 787,257 | 1,190,253 | Upgrade |
Gross Profit | 169,591 | 175,434 | 195,679 | 143,352 | 218,575 | Upgrade |
Selling, General & Admin | 146,672 | 134,278 | 171,564 | 157,732 | 175,601 | Upgrade |
Operating Expenses | 146,672 | 134,278 | 171,564 | 157,732 | 175,601 | Upgrade |
Operating Income | 22,919 | 41,156 | 24,116 | -14,380 | 42,974 | Upgrade |
Interest Expense | -46,183 | -46,866 | -56,431 | -25,960 | -26,777 | Upgrade |
Interest & Investment Income | 80,870 | 69,913 | 75,566 | 26,748 | 25,349 | Upgrade |
Currency Exchange Gain (Loss) | 784.41 | 379.34 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -749 | -17.96 | 26,857 | 79,537 | 7,306 | Upgrade |
EBT Excluding Unusual Items | 57,641 | 64,564 | 70,107 | 65,945 | 48,852 | Upgrade |
Gain (Loss) on Sale of Assets | -460.57 | - | - | - | - | Upgrade |
Pretax Income | 57,180 | 64,564 | 70,107 | 65,945 | 48,852 | Upgrade |
Income Tax Expense | 12,929 | 14,989 | 17,321 | 13,663 | 9,786 | Upgrade |
Net Income | 44,252 | 49,576 | 52,786 | 52,283 | 39,065 | Upgrade |
Preferred Dividends & Other Adjustments | - | 2,479 | - | - | - | Upgrade |
Net Income to Common | 44,252 | 47,097 | 52,786 | 52,283 | 39,065 | Upgrade |
Net Income Growth | -10.74% | -6.08% | 0.96% | 33.83% | -4.37% | Upgrade |
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 | Upgrade |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 16 | 16 | Upgrade |
Shares Change (YoY) | - | 0.01% | -0.01% | -0.01% | 0.01% | Upgrade |
EPS (Basic) | 2694.16 | 2867.39 | 3214.00 | 3183.00 | 2378.00 | Upgrade |
EPS (Diluted) | 2694.16 | 2867.39 | 3214.00 | 3183.00 | 2378.00 | Upgrade |
EPS Growth | -6.04% | -10.78% | 0.97% | 33.85% | -4.38% | Upgrade |
Free Cash Flow | -67,734 | -111,085 | 118,165 | -2,968 | -158,326 | Upgrade |
Free Cash Flow Per Share | -4123.83 | -6763.18 | 7194.70 | -180.68 | -9637.64 | Upgrade |
Gross Margin | 21.96% | 20.25% | 13.45% | 15.40% | 15.52% | Upgrade |
Operating Margin | 2.97% | 4.75% | 1.66% | -1.54% | 3.05% | Upgrade |
Profit Margin | 5.73% | 5.44% | 3.63% | 5.62% | 2.77% | Upgrade |
Free Cash Flow Margin | -8.77% | -12.82% | 8.12% | -0.32% | -11.24% | Upgrade |
EBITDA | 39,914 | 58,304 | 41,389 | 3,497 | 65,134 | Upgrade |
EBITDA Margin | 5.17% | 6.73% | 2.84% | 0.38% | 4.62% | Upgrade |
D&A For EBITDA | 16,995 | 17,147 | 17,273 | 17,877 | 22,159 | Upgrade |
EBIT | 22,919 | 41,156 | 24,116 | -14,380 | 42,974 | Upgrade |
EBIT Margin | 2.97% | 4.75% | 1.66% | -1.54% | 3.05% | Upgrade |
Effective Tax Rate | 22.61% | 23.21% | 24.71% | 20.72% | 20.03% | Upgrade |
Revenue as Reported | 772,251 | 866,319 | 1,454,563 | 930,609 | 1,408,828 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.